Early embryonic administration of xenoestrogens alters vasotocin system and male sexual behavior of the Japanese quail.
The copulatory behavior and the parvocellular vasotocin (VT) system of the nucleus of the stria terminalis (BST) are sexually dimorphic in the Japanese quail. Embryonic administration of estradiol benzoate (EB) induces an organizational effect determining the disappearance of such a dimorphism (male shows behavior and cerebral phenotype of the female). The VT parvocellular system can therefore be considered an accurate marker of the sexual differentiation of brain circuits and a very sensitive indicator of the activity of estrogen-like substances on neural circuits. To test this hypothesis we administered diethylstilbestrol (DES), a powerful synthetic xenoestrogen, genistein (GEN), a phytoestrogen produced by soy, and bisphenol A (BPA). After 3 days of incubation, quail eggs were injected with vehicle, EB, DES, GEN or BPA. Administration of BPA caused an early blockage of development and no further analyses were done on the BPA groups. At puberty, the copulatory behavior of EB- or DES-treated male quail was totally abolished, whereas only the highest doses of GEN determined a significant decrease of the behavior. After the tests, the animals were sacrificed and perfused. The fractional area (FA) covered by VT immunoreactivity was analyzed in BST, medial preoptic nucleus, and lateral septum by computerized image analysis. The FA was significantly reduced after treatment with EB, DES and GEN at high doses. These results confirm that the sexually dimorphic VT system of the Japanese quail is a sensible indicator of the effects of xenoestrogens at the level of the central nervous system.
Panzica
GianCarlo
G
Rita Levi Montalcini Center for Brain Repair, Laboratory of Neuroendocrinology, Department of Anatomy, Pharmacology and Forensic Medicine, University of Torino, c.so M. D'Azeglio 52, 10126 Torino, Italy. giancarlo.panzica@unito.it
Mura
Elena
E
Pessatti
Marzia
M
Viglietti-Panzica
Carla
C
D000818:Animals; D001559:Benzhydryl Compounds; D003370:Coturnix / Q000502:physiology*; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000633:toxicity; D004625:Embryo, Nonmammalian / Q000187:drug effects*; D004967:Estrogens / Q000008:administration & dosage* / Q000633:toxicity; D005260:Female; D019833:Genistein / Q000008:administration & dosage / Q000633:toxicity; D008297:Male; D010636:Phenols / Q000008:administration & dosage / Q000633:toxicity; D048789:Phytoestrogens / Q000008:administration & dosage / Q000633:toxicity; D012686:Septal Nuclei / Q000737:chemistry / Q000187:drug effects / Q000196:embryology; D012726:Sexual Behavior, Animal / Q000187:drug effects*; D014668:Vasotocin / Q000032:analysis / Q000502:physiology*; D000098826:Bisphenol A Compounds
D001559:Benzhydryl Compounds; D004054:Diethylstilbestrol; D004967:Estrogens; D019833:Genistein; D010636:Phenols; D048789:Phytoestrogens; D014668:Vasotocin; C006780:bisphenol A; D000098826:Bisphenol A Compounds